Business
Is the CSL (ASX:CSL) vaccine business under threat?
Image source: Getty Images
The CSL Limited (ASX: CSL) share price has been underperforming the ASX 200 in 2021.
Since the start of the year, the biotherapeutics company’s shares are down 2%. This compares to a 10% gain by the benchmark index.
Why is the CSL share price…
Continue Reading
-
General11 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General10 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
General13 hours agoPublisher ditches David Walliams after harassment claim
-
General13 hours agoThe Iranian-Australian community | The Spectator Australia